Baron Silver Stevens Financial Advisors, LLC Precigen, Inc. Transaction History

Baron Silver Stevens Financial Advisors, LLC

$569 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$1.41 - $2.79 $5,358 - $10,602	3,800 New	3,800 $400,000
Q1 2021 Apr 27, 2021	SELL	$6.74 - $10.95 $25,612 - $41,610	-3,800 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$3.75 - $10.56 $14,250 - $40,128	3,800 New	3,800 $38,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

Third Security, LLC

83.5M
Shares

$75.1 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$16.1 Million
0.92% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$9.78 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$9.22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$7.5 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $187M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Silver Stevens Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Silver Stevens Financial Advisors, LLC with notifications on news.

Account